SEC to take up Zydus Cadila's EUA application this week, says official

Zydus developed the vaccine, ZyCov-D with the support of the central government’s Department of Biotechnology and the Indian Council of Medical Research (ICMR). It has shown 66.6% efficacy in an interim study.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dMo3iv
via IFTTT